BSE filing, NSE: EIDPARRY. Summary written from the filing by ALFA Finder's alert engine.
EID Parry (India) Ltd: key numbers
- Share price
- ₹620.70
- Market cap
- ₹11,046 Cr
- Revenue (annual)
- ₹38,534 Cr
- Net profit (annual)
- ₹569.5 Cr
- P/E (TTM)
- 23.8×Sector 26.2×
- Promoter holding
- 41.28%+0.00% QoQ
- FII holding
- 9.63%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from EID Parry (India) Ltd
All →EID Parry (India) Other Announcement
EID Parry India Ltd filed its quarterly shareholding pattern as of September 30, 2026, disclosing promoter and public share distribution in accordance with regulatory requirements.
EID Parry (India) Management Change
Chandrasekar V R, Sr. AVP and Chief Information Officer (CIO) of E.I.D.- Parry (India) Limited, has resigned effective December 31, 2026.
EID Parry (India) Other Announcement
EID Parry India Ltd filed its quarterly shareholding pattern for the period ended June 30, 2026. The filing includes details on changes in promoter/promoter group holdings.
EID Parry (India) Capital Structure Change
SBI Mutual Fund increased its stake in EID Parry India Ltd by purchasing 78,142 shares. Its total shareholding now stands at 9.1363%.
EID Parry (India) Other Announcement
CRISIL ESG Ratings & Analytics has independently assigned an ESG rating of 61 (Strong) to E.I.D. - Parry (India) Limited for FY 2025-26.
EID Parry (India) Earnings Call Transcript: Key Takeaways
Management pivots to margin-accretion via CPG restructuring and Neutra growth as core sugar operations face feedstock shortages and rising cane costs in TN/AP.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date